Skip to main content
Clinical Trials/NL-OMON26239
NL-OMON26239
Not yet recruiting
Not Applicable

Compensatory Reading Training in Homonymous Visual Field Disorders - a Pilot Study

Royal Dutch Visio, Bartiméus0 sites10 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Royal Dutch Visio, Bartiméus
Enrollment
10
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Royal Dutch Visio, Bartiméus

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • ? Homonymous visual field defect (at least a quadrantanopia, either right\-sided or left\-sided) due to acquired post\-chiasmatic brain injury
  • ? At least three months between onset HVFD and the first measurement
  • ? Near visual acuity \>\= 0\.5 with patient’s own current correction
  • ? MMSE score \>\=24
  • ? Age \>\= 18 years
  • ? Presence of by participant formulated treatment goal regarding reading

Exclusion Criteria

  • A subject who meets any of the following criteria will be excluded from participation in this study:
  • ? Additional visual field defect (at least cluster) in ipsilesional visual hemi\-field
  • ? Pre\-existing dyslexia/ illiteracy/ low literacy/ other pre\-morbid reading problems
  • ? No clear neurological cause of HVFD
  • ? Presence of comorbid neglect
  • The following criteria are made on the premise that, when present, they will impair the ability to successfully follow the intervention:
  • ? Communication difficulties (e.g. severe hearing impairment, no fluent understanding of Dutch language, severe aphasia as indicated by the Token test)
  • ? Negative advice of treatment team regarding reading intervention participation, due to e.g. severe psychiatric, cognitive or visual perception disorders, problems with health, motivation or illness awareness or misuse of drugs/alcohol/medication
  • ? Additional visual disturbances (e.g. diplopia, metamorphopsia, low contrast sensitivity)

Outcomes

Primary Outcomes

Not specified

Similar Trials